Exact Mass: 418.2539704
Exact Mass Matches: 418.2539704
Found 85 metabolites which its exact mass value is equals to given mass value 418.2539704
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
CPA(18:1(11Z)/0:0)
cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
CPA(18:1(9Z)/0:0)
cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
MFA
Mfa is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Mfa can be found in french plantain, which makes mfa a potential biomarker for the consumption of this food product. MFA may refer to: .
Ophiopogonoside A
Ophiopogonoside A is a natural product found in Ophiopogon japonicus and Liriope muscari with data available.
(1R,4R,5R,7R,10S)-10,11,15-trihydroxyguaiane 11-O-beta-D-glucopyranoside
(2E,4E,6E)-cyclo-[(NMe-L-Ala)-L-Val-(Nalpha-octa-2,4,6-trienoyl-L-Orn)]|sclerotiotide A
C22H34N4O4 (418.25799240000003)
celerioside E|eudesmane-1beta,4alpha,11-triol 11-O-beta-D-glucopyranoside
eudesman-3,4alpha,11-triol-11-O-beta-D-glucopyranoside
(2E,6E)-10-beta-D-glucopyranosyl-1,10,11-trihydroxy-3,7,11-trimethyldodeca-2,6-diene
C22H34N4O4_N-Methyl-N-[(2E,4E,6E)-2,4,6-octatrienoyl]valylalanylprolinamide
C22H34N4O4 (418.25799240000003)
Gly Lys Lys Ser
Gly Lys Ser Lys
Gly Ser Lys Lys
Lys Gly Lys Ser
Lys Gly Ser Lys
Lys Lys Gly Ser
Lys Lys Ser Gly
Lys Ser Gly Lys
Lys Ser Lys Gly
Ser Gly Lys Lys
Ser Lys Gly Lys
Ser Lys Lys Gly
6-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-(trimethylsilyl)furo[3,2-b]pyrid
C22H38N2O2Si2 (418.24716879999994)
1-(9Z,12Z)-octadecadienylglycerone 3-phosphate
A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as (9Z,12Z)-octadecadienyl.
(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (9Z)-octadec-9-enoate
(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (11Z)-octadec-11-enoate
1-oleoyl-sn-glycerol 2,3-cyclic phosphate
A 1-acyl-sn-glycerol 2,3-cyclic phosphate having oleoyl as the 1-O-acyl group.
1-Oleylglycerone 3-phosphate(2-)
A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleylglycerone 3-phosphate; major species at pH 7.3.
2-[(5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
n-(2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl)octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)
2-{[1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,4e,6z)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)
(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(3s,6e,10e)-2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4r,5r)-4-{[(3r,4ar,5s,8as)-3-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}hexane-1,2,3,5,6-pentol
(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,7s,8as)-4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3r,4s,5r,6s,7s,11r,12s,13r,14r)-14-ethyl-4,6,9,12-tetrahydroxy-9-(hydroxymethyl)-3,5,7,11,13-pentamethyl-1-oxacyclotetradecane-2,10-dione
(2e,4e,6e)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)
(2r,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s,5s,6s)-2-{[(1r,2s,4ar,5r,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(4as,6as,12br,14as,14bs)-10-hydroxy-6a,9,12b,14a-tetramethyl-2-methylidene-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-4a-carbaldehyde
2-[(3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,2s,4as,5s,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-({2-[(2r,4ar,5s,8r,8ar)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-{[4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,4e)-n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)
3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione
(2r,3r,4s,5s,6r)-2-{[(1s,4s,4as,6s,8as)-4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(6e)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6s)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(8as,11r,12ar,12bs,14as)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione
13-isopropyl-15-[3-methoxy-5-(1h-pyrrol-2-yl)furan-2-yl]-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(15),2,14(16)-triene
(2s,3s,4s,5s,6s)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6s)-2-{[(3s,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4r,5r,6s)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,4e,6e)-n-[(3s,6s,9s)-2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl]octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)
2-{[4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid
C22H34N4O4 (418.25799240000003)